Kristi Sikes
Psychiatry · The Woodlands, TXNPI 1881989788
Payments from drug & device makers
Across 363 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$849
- Teva Pharmaceuticals USA, Inc.$380
- Takeda Pharmaceuticals U.S.A., Inc.$343
- Neurocrine Biosciences, Inc.$321
- Johnson & Johnson$289
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,31798%
- Education$1202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 97 | $1,271 |
| AbbVie(2 entities) | 78 | $849 |
| Teva Pharmaceuticals USA, Inc. | 18 | $380 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $343 |
| Neurocrine Biosciences, Inc. | 19 | $321 |
| Johnson & Johnson | 15 | $289 |
| Alkermes, Inc. | 15 | $256 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $241 |
| Lundbeck LLC | 12 | $192 |
| Corium, LLC | 13 | $185 |
| Bausch Health US, LLC | 9 | $140 |
| Vanda Pharmaceuticals Inc. | 8 | $139 |
| Sunovion Pharmaceuticals Inc. | 5 | $101 |
| Eisai Inc. | 6 | $95 |
| Axsome Therapeutics, Inc. | 5 | $86 |
| Ironshore Pharmaceuticals Inc. | 5 | $79 |
| Indivior Inc. | 3 | $69 |
| Adlon Therapeutics L.p. | 3 | $64 |
| Idorsia Pharmaceuticals US Inc | 3 | $52 |
| Avanir Pharmaceuticals, Inc. | 3 | $43 |
| Shire North American Group Inc | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Biogen | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| Orexo US, Inc. | 2 | $23 |
| Noven Therapeutics, LLC | 1 | $21 |
| Merck | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
| Neuronetics, Inc. | 1 | $8 |
How this compares
$5,437 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 26 | $204,467 |
| RexultiBrexpiprazole | 27 | $53,263 |
| TrintellixVortioxetine Hydrobromide | 19 | $8,606 |
| Duloxetine Hcl | 75 | $1,299 |
| Trazodone Hcl | 76 | $1,014 |
| Lurasidone Hcl | 25 | $940 |
| Escitalopram Oxalate | 56 | $837 |
| Bupropion XlBupropion Hcl | 49 | $820 |
| Fluoxetine Hcl | 46 | $797 |
| Buspirone Hcl | 36 | $696 |
| Aripiprazole | 23 | $686 |
| Pregabalin | 35 | $684 |
| Gabapentin | 44 | $643 |
| Mirtazapine | 42 | $547 |
| Quetiapine Fumarate | 50 | $509 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $321 | $204,46726 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,271 | $53,26327 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $343 | $8,60619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in The Woodlands
- Marshall LucasThe Woodlands$4.8M
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Sejal MehtaPlano$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.